Lasa Supergenerics Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2025
LASA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lasa Supergenerics held its 10th AGM on September 30, 2025, from 11:00 AM to 11:20 AM via video conferencing, with 36 members present. Chairman and Managing Director Dr. Omkar Herlekar chaired the meeting, and 14 business items were discussed, including 2 ordinary and 12 special resolutions. Key proposals included changing the designation of four directors (including one woman director) to Non-Executive Independent Directors, approving additions to the company's main business objects, sanctioning managerial remuneration in case of inadequate or no profits, and approving material related party transactions. The company also sought shareholder approval to sell or transfer a non-operational unit at MIDC Lote Parshuram, including associated patents and IPR rights, and to approve donations including to the Dr. Omkar Herleker Foundation. The e-voting facility was provided by Bigshare Services, and M/s Shravan A. Gupta & Associates acted as scrutinizer. Voting results will be submitted to stock exchanges within two working days.
This is a procedural disclosure with no immediate price impact, but it flags several future-sensitive items for shareholders — particularly the proposed sale of a non-operational manufacturing unit along with patents, the expansion of business activity scope, donations to a related-party foundation, and approval of managerial remuneration even in loss-making years. Watch the upcoming voting results for shareholder approval levels on these resolutions.